Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery Disease

This study has been completed.
Information provided by:
Synvista Therapeutics, Inc Identifier:
First received: June 23, 2007
Last updated: July 1, 2008
Last verified: June 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2008
  Estimated Primary Completion Date: No date given